BioStat’s rED Cap software receives trademark status
BioStat International’s rED Cap, proprietary, web-based clinical trial data management software, has received trademark status. This distinction follows the October 2011 rollout of rED Cap during the BioFlorida Annual Conference.
Thanks to its navigation and usage-based, zero-licensing pricing model, rED Cap has received strong accolades in its first few months of release.
For multi-site clinical research trials, pharmaceutical research, development and marketing and medical observational studies, rED Cap provides a comprehensive Web-based data management solution to collect and store data, all in a secure environment (rED Cap meets compliance requirements for both HIPAA and CFR21 Part 11).
To support quality research, rED Cap also features a customizable electronic case report form, flexible workflow, dynamic reporting and data status and powerful data validation capability. BSI data management CRO service—offered with each rED Cap study—can provide assistance to a research team in efficient project management and experienced data analysis for meeting study objectives.